Your browser doesn't support javascript.
loading
A 30-year experience in using oral methotrexate as initial treatment for gestational trophoblastic neoplasia regardless of risk group.
Faaborg, Louise; Niemann, Isa; Ostenfeld, Eva B; Hansen, Estrid S; Sunde, Lone; Lindegaard, Jacob C.
  • Faaborg L; a Department of Oncology , Aarhus University Hospital , Aarhus , Denmark.
  • Niemann I; b Department of Obstetrics and Gynecology , Aarhus University Hospital , Aarhus , Denmark.
  • Ostenfeld EB; c Department of Clinical Epidemiology , Aarhus University Hospital , Aarhus , Denmark.
  • Hansen ES; d Department of Pathology , Aarhus University Hospital , Aarhus , Denmark.
  • Sunde L; e Department of Clinical Genetics Aarhus University Hospital , Aarhus , Denmark.
  • Lindegaard JC; f Department of Biomedicine , Aarhus University Hospital , Aarhus , Denmark.
Acta Oncol ; 55(2): 234-9, 2016.
Article en En | MEDLINE | ID: mdl-26106854
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Metotrexato / Enfermedad Trofoblástica Gestacional Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Female / Humans / Middle aged / Pregnancy Idioma: En Año: 2016 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Metotrexato / Enfermedad Trofoblástica Gestacional Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Female / Humans / Middle aged / Pregnancy Idioma: En Año: 2016 Tipo del documento: Article